Search

You searched for "infection"

1028 results found

Results from the REDUCE study

1 November 2016 | | URO - Urologic Oncology
Subjects in this paper were part of the Reduction by Dutasteride of PCa Events (REDUCE) study, a clinical trial enrolling men who had undergone a single negative prostate biopsy within six months of enrollment and subjecting them to a repeat...

The Urology Foundation

1 July 2015 | | URO - Core Urology
The Urology Foundation (TUF) is the only charity in the United Kingdom that raises money for research into all types of urological disease. Our ultimate aim as a charity is to discover the causes of urology cancers and conditions, to...

Bupa covers accurate PSE prostate cancer blood test

9 April 2025 | Contracts & Distributors, Research & Development
A new era in prostate cancer detection is emerging with the EpiSwitch® PSE blood test, a highly accurate tool that enhances early diagnosis while significantly cutting false positives. Now covered by Bupa as a pre-biopsy test, PSE has demonstrated 94%...

Consent Part 2

5 September 2022 | | URO - Core Urology
See Part 1 on this topic here Case 1 A 77 year old lady presents to the Emergency Department confused and generally unwell. She is septic and, on imaging, is found to have a 9mm obstructing right sided proximal ureteric...

Theatre utilisation in urology theatres at a UK tertiary referral centre

1 September 2014 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatrics, URO - Functional / Reconstructive Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Introduction The efficient use of operating theatres is important to ensure optimum cost-benefit for the hospital and to clear waiting lists. The key elements in the efficient use of operating theatres are: effective management and good communication, trained staff, appropriate...

In conversation with Mr Duncan Summerton

1 November 2018 | URO - Core Urology
Urology News was delighted to recently have a chat with Duncan Summerton, Consultant Urological Surgeon in Leicester and new President of BAUS. Duncan with a native wild brown trout caught on a dry fly on the Derbyshire Wye. Can you...

In conversation with Ahmed Ali

12 May 2025 | URO - Core Urology
We were delighted to chat to Ahmed Ali about the journey to pursing a urological career in the UK and his decision to found the Arabic-British Urological Society. You grew up in Iraq and went to university in Baghdad; what...

The 10 commandments of laparoscopic urology

1 March 2015 | | URO - Core Urology
Laparoscopic urologic procedures continue to attract the interest of trainees, consultants and the public, and the demand for training is on the increase [1,2,3]. The vast majority of laparoscopic procedures are laparoscopic nephrectomies and this is certainly the most common...

Prostate Scotland statement on National Screening Committee recommendation

2 December 2025
Prostate Scotland notes the recommendation from the UK National Screening Committee (NSC) on Friday 28 November 2025 to introduce targeted prostate cancer screening only for men with confirmed BRCA1 or BRCA2 gene variants. While this represents an important first step...

Intelligent triage: improving outpatient efficiency

13 March 2023 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatrics, URO - Core Urology, URO - Functional / Reconstructive Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Background Improving outpatient (OP) efficiency and service structure is of paramount importance as the NHS seeks to manage ever increasing demand in the wake of the COVID-19 pandemic. As we re-establish services and attempt to clear the backlog, new ways...

Neuroendocrine bladder tumour

5 February 2025 | | URO - Urologic Oncology
A 75-year-old male with a history of prostate adenocarcinoma (T3b/T4 N1 M1b, Gleason 4+3) on Zoladex® and enzalutamide, presented with visible haematuria. His prostate specific antigen (PSA) had decreased from 43.6ug/L in December 2022 to 0.02ug/L. He also had a...

In conversation with Neil Harvey

21 December 2021 | URO - Core Urology
We were delighted to catch up with Neil Harvey, Chair of the BAUS Section of Trainees (BSoT) about his life as a trainee urologist and his plans for the association. Can you tell us a little bit about what led...